The development of new PET tracers that target specific receptors has increased the popularity of occupancy studies for drug development. Critical questions, such as whether the drug has crossed the blood-brain barrier, engaged with its target receptor, and whether the dose achieves sufficient receptor binding for a desired therapeutic effect, can be answered by applying fully quantitative data analysis approaches to kinetic modeling.